NextCure, Inc.NXTCNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
5.02%
↓ 23% vs avg
Percentile
P55
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
6.48%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 5.02% |
| Q3 2025 | -12.25% |
| Q2 2025 | -14.09% |
| Q1 2025 | 4.87% |
| Q4 2024 | -4.62% |
| Q3 2024 | 10.37% |
| Q2 2024 | -22.66% |
| Q1 2024 | 10.12% |
| Q4 2023 | -14.00% |
| Q3 2023 | -19.31% |
| Q2 2023 | 5.29% |
| Q1 2023 | 9.60% |
| Q4 2022 | -13.34% |
| Q3 2022 | 7.69% |
| Q2 2022 | -7.73% |
| Q1 2022 | 19.55% |
| Q4 2021 | -2.12% |
| Q3 2021 | -18.25% |
| Q2 2021 | 23.91% |
| Q1 2021 | 17.36% |
| Q4 2020 | -11.33% |
| Q3 2020 | -0.26% |
| Q2 2020 | 30.18% |
| Q1 2020 | 37.05% |
| Q4 2019 | -0.15% |
| Q3 2019 | -3.39% |
| Q2 2019 | 63.59% |
| Q1 2019 | 102.56% |
| Q4 2018 | -11.46% |
| Q3 2018 | 6.81% |
| Q2 2018 | 8.39% |
| Q1 2018 | 0.00% |